Linee guida - Le Buone Pratiche di cura nei Disturbi del ...

116 Linee guida REGIONALI per la diagnosi ed il trattamento dei disturbi del comportamento alimentare
Masheb R.M. & Grilo C.M. (2007). Rapid response predicts treatment outcomes in binge
eating disorder; implications for stepped care. J Consult Clin Psychol, 75, 639–44.
McElroy S., Arnold L., Keck P., Shapira N., Rosenthal N., Hudson J. et al. (2002). Topiramate
in the treatment of DAI associate with obesity (Abstract 093). In: 2002 International
Conference on Eating Disorders. Office AN, ed. Boston, MA, USA: Academy for Eating
Disorders, pag.65.
McKnight R.F. & Park R.J. (2010). Atypical antipsychotics and anorexia nervosa: a review.
Eur Eat Disorders, 18, 10–21.
Minuchin S., Rosman B.L. & Baker L. (1978), Psychosomatic Families. Anorexia Nervosa in
context. Harvard University Press.
Molinari E., Baruffi M., Croci M., Marchi S. & Petroni M.L. (2005). DAI in obesity: comparison
of different therapeutic strategies. Eating and Weight Disorders, 10(3), 154–61.
Munsch S., Biedert E., Meyer A., Michael T., Schlup B., Tuch A. &Margraf (2007). A randomized
comparison of cognitive behavioral therapy and behavioral weight loss treatment for
overweight individuals with binge eating disorder. Int J Eat Disord., 40(2), 102–13.
Murphy R., Streabler S., Cooper Z. & Faiburn C.G. (2010). Cognitive behavioral therapy for
eating disorders. Psychiatr Clin North Am., 33(3), 611–27.
NevonenL. & BrobergA.G. (2006). A comparison of sequenced individual and group
psychoterapy for patients with bulimia nervosa. Int J Eat Disord, 39:117–127.
NICE (National Institute for Clinical Excellence) (2004).Eating disorders. Core interventions
in the treatment and management of anorexia nervosa, bulimia nervosa and related eating
disorders. Clinical Guideline 9. National Collaborating Centre for Mental Health.
Ostuzzi R. (1997). La riabilitazione nutrizionale dei DCA. Quon,4, 13–16.
Pallanti S., Quercioli L. & Ramacciotti A. (1997). Citalopram in anorexia nervosa. Eating and
Weight Disorders, 2,216–21.
Pearlstein T., Spurell E., Hohlstein L.A., et al. (2003). A double blinde, placebo–controlled
trial of fluvoxamine in binge–eating disorder: a high placebo response. Arch Womens Ment
Health,6,147–51.
Perkins S.J., Murphy R.M., Schmidt U.S. & Williams C. (2009). Self–help and guided self–help
for eating disorders. The Cochrane Collaboration. In The Cochrane Library, Issue 1.
Powers P. (2002). Olanzapine in the treatment of anorexia nervosa. In: 2002 International Conference
on Eating Disorders. Office AN, ed. Boston, MA, USA: Academy for Eating Disorders, pag.6.